Open access
Aug 2026
Integrated In Silico Discovery of Thymoquinone Analogs Targeting the Keap1–Nrf2 Pathway for Amyotrophic Lateral Sclerosis Therapy
This study identifies structurally tractable TQ analogs with improved predicted potency and establishes a robust computational framework for neuroprotective discovery as redox‐modulating agents in ALS.
Jabir C Nalicho, P. Mabeyo, Andrew S. Paluch et al.
· ChemistryOpen · 0 citations